Skip to main content
logo
MedCap AB (publ) (STO:MCAP)
Sweden flag Sweden · Delayed Price · Currency is SEK
558.00
-10.50 (-1.85%)
Sep 4, 2026, 5:30 PM CET

Revenue by Geography

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Sweden Revenue
1.01B957.30M898.40M
Nordic (ex-Sweden) Revenue
664.80M612.50M448.60M
Europe (ex-Nordic) Revenue
542.60M484.60M384.70M
Rest of the World Revenue
42.80M53.70M75.10M
Revenue (Other)
63.50M42.80M48.90M
Revenue (Total)
2.32B2.15B1.86B

Revenue Breakdown

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Assistive Tech Revenue
1.05B981.80M767.20M
Medtech Revenue (Post-Q2 2023 Reporting)
722.60M689.60M607.70M
Medtech Revenue (Pre-Q3 2023 Reporting)
1.77B1.67B1.37B
Specialty Pharma Revenue
486.20M436.60M431.80M
Revenue (Other)
-1.71B-1.63B-1.33B
Revenue (Total)
2.32B2.15B1.86B

Revenue Breakdown 2

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Pharmaceuticals Revenue
473.80M424.80M420.50M
Assistive Technology Revenue
1.05B981.30M765.90M
Medical Devices Revenue
322.50M320.10M322.70M
Nutrition & Other Food Revenue
363.40M333.60M251.80M
Other Product Revenue
49.80M48.20M45.90M
Revenue (Total)
2.32B2.15B1.86B

Adjusted EBITDA

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Assistive Tech Adjusted EBITDA
320.20M289.50M212.00M
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting)
157.00M145.90M138.30M
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting)
477.20M435.40M350.30M
Specialty Pharma Adjusted EBITDA
73.50M45.70M59.20M
Other and Eliminations from Adjusted EBITDA
-28.70M-24.80M-21.70M
Operating Income (Other)
-176.50M-153.40M-115.50M
Operating Income (Total)
345.50M302.90M272.30M

EBIT

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Apr '17 Apr '16
Assistive Tech Operating Profit
240.70M217.30M164.10M
Medtech Operating Profit (Post-Q2 2023 Reporting)
114.30M103.20M98.70M
Medtech Operating Profit (Pre-Q3 2023 Reporting)
355.00M320.50M262.80M
Specialty Pharma Operating Profit
21.10M9.20M33.40M
Other and Eliminations from Operating Profit
-30.70M-26.80M-23.90M
Operating Income (Other)
100.00K--
Operating Income (Total)
345.50M302.90M272.30M